BioCentury | Aug 18, 2014
Company News

Sinovac, Beijing Centers for Disease Control and Prevention infectious news

...on demand during the flu season. In 2013, Sinovac supplied about 400,000 doses of its Anflu...
BioCentury | Apr 29, 2013
Clinical News

Anflu regulatory update

...Sinovac said Mexico granted a certificate of approval to commercialize its Anflu seasonal flu vaccine. The...
...the certificate is valid until April 1, 2018. Sinovac Biotech Ltd. (NASDAQ:SVA), Beijing, China Product: Anflu...
BioCentury | Jan 29, 2010
Top Story

Sinovac raises $57.5 million

...inactivated hepatitis A vaccine ; Bilive , a combination hepatitis A and B vaccine; and Anflu...
BioCentury | Jan 21, 2010
Financial News

Sinovac proposes follow-on

...inactivated hepatitis A vaccine ; Bilive , a combination hepatitis A and B vaccine; and Anflu...
BioCentury | Sep 7, 2009
Company News

Sinovac, Beijing Public Health Bureau infectious news

...the four manufacturers selected by the bureau to supply seasonal influenza A (H1N1) vaccine. Sinovac's Anflu...
BioCentury | Oct 29, 2007
Company News

Sinovac, Beijing Public Health Bureau infectious news

...The bureau purchased 140,000 adult doses of SVA's Anflu influenza vaccine for CNY 34 ($4.53) per...
BioCentury | Aug 6, 2007
Company News

Sinovac, GlaxoSmithKline sales and marketing update

...GSK's GlaxoSmithKline Investment Co. Ltd. unit will distribute the adult dosage formulation of SVA's Anflu influenza...
BioCentury | Oct 17, 2005
Strategy

Flu vaccine manufacturers

...Cell culture-derived influenza virus Preclin; enter clinic 4Q05 Sinovac Biotech(also known as Beijing Kexing Bioproducts) AnFlu...
Items per page:
1 - 8 of 8